Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study

Schizophrenia Research

Volumn 130, Issue 1-3, 2011, Pages 47-52

  Stroup, T Scott ^a   Appelbaum, Paul S ^a   Gu, Hongbin ^b   Hays, Spencer ^b   Swartz, Marvin S ^c   Keefe, Richard S E ^c   Kim, Scott Y ^d   Manschreck, Theo C ^e   Boshes, Roger A ^e   McEvoy, Joseph P ^c   Lieberman, Jeffrey A ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Decision making capacity; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL RESEARCH; COGNITION; COMPREHENSION; DISEASE SEVERITY; FEMALE; HUMAN; INFORMED CONSENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT DECISION MAKING; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BIOMEDICAL RESEARCH; COGNITION DISORDERS; DECISION MAKING; FEMALE; HUMANS; INFORMED CONSENT; LONGITUDINAL STUDIES; MALE; MENTAL COMPETENCY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC;

EID: 79960315812     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.04.012     Document Type: Article

References (26)

1. Addington D., Addington J., et al. A depression rating scale for schizophrenics. Schizophr. Res. 1990, 3(4):247-251.
2. Appelbaum P.S. Decisional capacity of patients with schizophrenia to consent to research: taking stock. Schizophr. Bull. 2006, 32(1):22-25.
3. Appelbaum P., Grisso T. The MacArthur Competence Assessment Tool-Clinical Research 2001, Florida, Professional Resource Press, Sarasota.
4. Awad A.G. Subjective response to neuroleptics in schizophrenia. Schizophr. Bull. 1993, 19(3):609-618.
5. Carpenter W.T., Gold J.M., et al. Decisional capacity for informed consent in schizophrenia research. Arch. Gen. Psychiatry 2000, 57(6):533-538.
6. Dunn L.B., Lindamer L.A., et al. Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. Am. J. Geriatr. Psychiatry 2002, 10(2):142-150.
7. Dunn L.B., Candilis P.J., et al. Emerging empirical evidence on the ethics of schizophrenia research. Schizophr. Bull. 2006, 32(1):47-68.
8. Dunn L.B., Nowrangi M.A., et al. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am. J. Psychiatry 2006, 163(8):1323-1334.
9. Heaton R.K., Gladsjo J.A., et al. Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry 2001, 58(1):24-32.
10. Hogan T.P., Awad A.G., et al. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 1983, 13(1):177-183.
11. Kay S.R., Fiszbein A., et al. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
12. Keefe R.S., Mohs R.C., et al. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr. Bull. 2003, 29(1):45-55.
13. Kim S.Y., Appelbaum P.S., et al. Determining when impairment constitutes incapacity for informed consent in schizophrenia research. Br. J. Psychiatry 2007, 191:38-43.
14. Kovnick J.A., Appelbaum P.S., et al. Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatr. Serv. 2003, 54(9):1247-1252.
15. Moser D.J., Schultz S.K., et al. Capacity to provide informed consent for participation in schizophrenia and HIV research. Am. J. Psychiatry 2002, 159(7):1201-1207.
16. Moser D.J., Reese R.L., et al. Informed consent in medication-free schizophrenia research. Am. J. Psychiatry 2005, 162(6):1209-1211.
17. Moser D.J., Reese R.L., et al. Using a brief intervention to improve decisional capacity in schizophrenia research. Schizophr. Bull. 2006, 32(1):116-120.
18. National Bioethics Advisory Commission Research involving persons with mental disorders that may affect decisionmaking capacity. I: Report and Recommendations of the National Bioethics Advisory Commission 1998.
19. Palmer B.W., Savla G.N. The association of specific neuropsychological deficits with capacity to consent to research or treatment. J. Int. Neuropsychol. Soc. 2007, 13(6):1047-1059.
20. Palmer B.W., Nayak G.V., et al. Treatment-related decision-making capacity in middle-aged and older patients with psychosis: a preliminary study using the MacCAT-T and HCAT. Am. J. Geriatr. Psychiatry 2002, 10(2):207-211.
21. Palmer B.W., Dunn L.B., et al. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch. Gen. Psychiatry 2004, 61(3):230-236.
22. Palmer B.W., Dunn L.B., et al. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch. Gen. Psychiatry 2005, 62(7):726-733.
23. Stroup S., Appelbaum P. The subject advocate: protecting the interests of participants with fluctuating decisionmaking capacity. IRB 2003, 25(3):9-11.
24. Stroup T.S., Appelbaum P.S. Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study. Schizophr. Bull. 2006, 32(1):147-152.
25. Stroup T.S., McEvoy J.P., et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr. Bull. 2003, 29(1):15-31.
26. Stroup S., Appelbaum P., et al. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophr. Res. 2005, 80(1):1-8.